Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Experimental drug for rheumatoid arthritis prevents side effect of stem cell transplants

Experimental drug for rheumatoid arthritis prevents side effect of stem cell transplants

Researchers identify novel pathway in development of AML with poor prognosis

Researchers identify novel pathway in development of AML with poor prognosis

Low-cost blood test for multiple myeloma can deliver same diagnostic information as bone biopsy

Low-cost blood test for multiple myeloma can deliver same diagnostic information as bone biopsy

Researchers discover new information related to rare form of leukemia

Researchers discover new information related to rare form of leukemia

Experts propose new solutions to increase benefit, affordability of targeted cancer medicines

Experts propose new solutions to increase benefit, affordability of targeted cancer medicines

Mouse study shows how tungsten accumulates in the bones

Mouse study shows how tungsten accumulates in the bones

Two immune checkpoint inhibitors efficiently block leukemia development in preclinical tests

Two immune checkpoint inhibitors efficiently block leukemia development in preclinical tests

Cancer risk found to be three times greater after acute thrombosis in the leg

Cancer risk found to be three times greater after acute thrombosis in the leg

Engineered immune cells clear deadly pediatric brain tumor in mice

Engineered immune cells clear deadly pediatric brain tumor in mice

Research reveals immune suppressive role of soluble antibodies in tumor progression

Research reveals immune suppressive role of soluble antibodies in tumor progression

Experimental peptide drug shows promise against acute myeloid leukemia

Experimental peptide drug shows promise against acute myeloid leukemia

Research identifies link between rare gene variants and survival after blood and marrow transplant

Research identifies link between rare gene variants and survival after blood and marrow transplant

Scripps Florida researchers awarded $2.875 million to destroy common form of leukemia

Scripps Florida researchers awarded $2.875 million to destroy common form of leukemia

New class of drug holds potential to help patients with treatment-resistant cancers

New class of drug holds potential to help patients with treatment-resistant cancers

Study finds link between industry payments and prescription practices for two cancer types

Study finds link between industry payments and prescription practices for two cancer types

People living near oil and gas facilities may have greater health risks

People living near oil and gas facilities may have greater health risks

Scientists identify key genetic events responsible for initiating childhood leukemia

Scientists identify key genetic events responsible for initiating childhood leukemia

Researchers discover a new molecular cause for aggressive leukemia in children

Researchers discover a new molecular cause for aggressive leukemia in children

Study uncovers mechanism causing chronic GVHD after bone marrow transplant

Study uncovers mechanism causing chronic GVHD after bone marrow transplant

FDA grants accelerated approval to leukemia drug for patients with MRD-positive ALL

FDA grants accelerated approval to leukemia drug for patients with MRD-positive ALL

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.